[1. Singh R. Review literature on uterine carcinosarcoma. J Can Res Ther 2014;10:461-8.]Search in Google Scholar
[2. McCluggage WG. Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol. 2010 Mar;17(2):122-9.10.1097/PAP.0b013e3181cfe732]Search in Google Scholar
[3. F. Amant, E. Steenkiste, K. Schurmans, et al. Immunohistochemical expression of CD10 antigen in uterine adenosarcoma. Int J Gynecol Cancer, 14 (2004), pp. 1118-21.]Search in Google Scholar
[4. D’Angelo E, Prat J. Pathology of mixed Mullerian tumours. Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):705-18.10.1016/j.bpobgyn.2011.05.010]Search in Google Scholar
[5. Chaudhary YS, Illahi F, Moatasim A. Carcinosarcoma uterine unusual histologic presentation. Rawal Med J 2009;34:120-2.]Search in Google Scholar
[6. Wolfson AH, Wolfson DH, Sittler SY, Breton L, Markoe AM, Schwade JG, et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 1994;52:56-6210.1006/gyno.1994.1011]Search in Google Scholar
[7. Yildirim Y, Inal MM, Sanci M, Yildrim YK, Mit T, Polat M, et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: A report four cases. Int J Gynecol Cancer 2005;15:1239-42.10.1111/j.1525-1438.2005.00170.x]Search in Google Scholar
[8. Arenas M, Rovirosa A, Hernandez V, Ordi J, Jarcano S, Mellado B, et al. Uterine sarcomas in breast cases patients treated with tamoxifen. Int J Gynecol Cancer 2006;16:861-5.10.1111/j.1525-1438.2006.00415.x]Search in Google Scholar
[9. Wysowki DK, Honig SF, Beitz J. Uterine sarcoma associated with tamoxifen use. N Engl J Med 2002;346:1832-3.10.1056/NEJM200206063462319]Search in Google Scholar
[10. Kloos I, Delaloge S, Pautier P, Di Palma M, Goupil A, Duvillard P, et al. Tamoxifen related uterine carcinosarcomas occur under/after prolonged treatment: Report of five cases and review of literature. Int J Gynecol Cancer 2002;12:496-500.10.1136/ijgc-00009577-200209000-00015]Search in Google Scholar
[11. Hubalek M, Ramoni A, Muller-holzner E, Marth C. Malignant mixed mesodermal tumour after tamoxifen therapy for breast cancer. Gynecol Oncol 2004;95:264-6.10.1016/j.ygyno.2004.06.039]Search in Google Scholar
[12. Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA. Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 2007;31:1653-61.10.1097/PAS.0b013e3181161ba3]Search in Google Scholar
[13. Ablen EC, Smit VT, Wessels JW, de Deleeuw WJ, Cornelisse CJ, Fleuren GJ. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Mullerian tumours. J Pathol 1997;183:424-31.10.1002/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L]Search in Google Scholar
[14. Kuyumcuoglu U, Kale A. Homologous type malignant mixed Mullerian tumour of the uterus presenting as cervical mass. J Chin Med Assoc 2009;72:533-510.1016/S1726-4901(09)70423-X]Search in Google Scholar
[15. Molpus KL, Redline-Frazier S, Reed G, Burnett LS, Jones HW 3 rd . Postoperative pelvic irradiation in early stage uterine mixed Mullerian tumours. Eur J Gynecol Oncol 1998;19:541-6.]Search in Google Scholar
[16. Menczer J, Levy T, Piura B, Chetrit A, Altaraj M, Meirovitz M, et al. A comparison between different postoperative treatment modalities of uterine carcinosarcoma. Gynecol Oncol 2005;97:166-70.10.1016/j.ygyno.2004.12.006]Search in Google Scholar
[17. Wong L, See HT, Khoo-Tan HS, Low JS, Ng WT, Low JJ. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed Mullerian tumours of the uterine sarcomas. Int J Gynecol Cancer 2006;16:1364-9.]Search in Google Scholar
[18. Felix AS1, Stone RA, Bowser R, Chivukula M, Edwards RP, Weissfeld JL, Linkov F. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers. Int J Gynecol Cancer. 2011 Jul;21(5):877-84.10.1097/IGC.0b013e31821a62dd]Search in Google Scholar
[19. Tong SY1, Lee JM, Choi YJ, Lee JK, Kim JW, Cho CH, Kim SM, Park SY, Park CY, Kim KT. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma. Aust N Z J Obstet Gynaecol. 2012 Feb;52(1):44-8.10.1111/j.1479-828X.2011.01389.x]Search in Google Scholar
[20. Reed NS: Uterine sarcomas--the biggest challenge? Clin Oncol (R Coll Radiol) 2002, 14(1):50-3.10.1053/clon.2001.0043]Search in Google Scholar
[21. Norris HJ, Taylor HB: Postirradiation sarcomas of the uterus. Obstet Gynecol 1965, 26(5):689-94.]Search in Google Scholar
[22. Press MF, Scully RE: Endometrial “sarcomas” complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. Gynecol Oncol 1985, 21(2):135-54.10.1016/0090-8258(85)90246-X]Search in Google Scholar
[23. Clement PB, Oliva E, Young RH: Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifenassociated endometrial lesions. Int J Gynecol Pathol 1996, 15(3):222-9.10.1097/00004347-199607000-00006]Search in Google Scholar
[24. Clement PB, Scully RE: Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 1990, 21(4):363-81.10.1016/0046-8177(90)90198-E]Search in Google Scholar
[25. Verschraegen CF, Vasuratna A, Edwards C, Freedman R, Kudelka AP, Tornos C, Kavanagh JJ: Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience. Oncol Rep 1998, 5(4):939-44.10.3892/or.5.4.9399625851]Search in Google Scholar
[26. Gallardo A, Prat J: Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 2009, 33(2):278-88.10.1097/PAS.0b013e318181a80d18941402]Search in Google Scholar
[27. Zaloudek CJ, Norris HJ: Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases. Cancer 1981, 1548(2):354-66.10.1002/1097-0142(19810715)48:2<354::AID-CNCR2820480222>3.0.CO;2-Q]Search in Google Scholar
[28. Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS: Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 2001, 83(1):89-94.10.1006/gyno.2001.6334]Search in Google Scholar
[29. Clement PB, Scully RE: Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer 1974, 34(4):1138-49.10.1002/1097-0142(197410)34:4<1138::AID-CNCR2820340425>3.0.CO;2-9]Search in Google Scholar